FDA Adverse Event Malfunction Summary report: N

BACTEC PLASTIC MYCOSIS IC/F MEDIUM

MDR report key: 23452939 · Received November 3, 2025

Report

Report Number
2647876-2025-00657
Event Type
Malfunction
Date Received
November 3, 2025
Date of Event
October 13, 2025
Report Date
November 19, 2025
Manufacturer
BECTON DICKINSON CARIBE LTD.
Product Code
MDB
UDI-DI
00382904420178
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY: CATALOG 42017 BATCH NO. 5073093 THE CUSTOMER REPORTED A VACUUM DRAW ISSUE. NEITHER PHOTOS NOR RETURNED GOODS SAMPLES WERE RECEIVED. BD WAS UNABLE TO REPRODUCE CUSTOMER¿S EXPERIENCE WITH BACTEC PRODUCT. SATISFACTORY RESULTS WERE OBTAINED FROM RETENTION SAMPLES WHEN VISUALLY INSPECTED FOR ANY CAP DEFECT OR LEAKAGE. BATCH HISTORY RECORD REVIEW DID NOT IDENTIFY ANY EVIDENCE FOR WHICH THE CUSTOMER SUBMITTED THE COMPLAINT. A COMPLAINT HISTORY REVIEW WAS CONDUCTED AND ONLY THE CURRENT COMPLAINT WAS FOUND RELATING TO THE INCIDENT LOT NUMBER AND THE ¿AS REPORTED¿ DEFECT CODE. ADDITIONALLY, FIVE RANDOMLY SELECTED SAMPLES WERE INSPECTED FOR CAP INTEGRITY, ALL YIELDING SATISFACTORY RESULTS. VACUUM DRAW TEST WAS PERFORMED TO RETENTION SAMPLES WITH SATISFACTORY RESULTS. COMPLAINT IS UNCONFIRMED BASED ON RETENTION SAMPLES AND BATCH HISTORY RECORD REVIEW RESULTS. PRODUCT INSERT STATES THAT PRIOR TO USE, EACH VIAL SHOULD BE EXAMINED FOR EVIDENCE OF CONTAMINATION SUCH AS CLOUDINESS, BULGING OR DEPRESSED SEPTUM, OR LEAKAGE. DO NOT USE ANY VIAL SHOWING EVIDENCE OF CONTAMINATION. A CONTAMINATED VIAL COULD CONTAIN POSITIVE PRESSURE. IF A CONTAMINATED VIAL IS USED FOR DIRECT DRAW, GAS OR CONTAMINATED CULTURE MEDIA COULD BE REFLUXED INTO THE PATIENT¿S VEIN. VIAL CONTAMINATION MAY NOT BE READILY APPARENT. IF A DIRECT DRAW PROCEDURE IS USED, MONITOR THE PROCESS CLOSELY TO AVOID REFLUXING MATERIALS INTO THE PATIENT. PRIOR TO USE, THE USER SHOULD EXAMINE THE VIALS FOR EVIDENCE OF DAMAGE OR DETERIORATION. VIALS THAT ARE CRACKED OR LEAKING, OR DISPLAY TURBIDITY, CONTAMINATION, OR DISCOLORATION (DARKENING) SHOULD NOT BE USED. ON RARE OCCASIONS, A VIAL NECK MAY BE CRACKED AND THE NECK MAY BREAK DURING REMOVAL OF THE FLIP-OFF CAP OR IN HANDLING. ALSO, ON RARE OCCASIONS A VIAL MAY NOT BE SEALED SUFFICIENTLY. IN BOTH CASES THE CONTENTS OF THE VIALS MAY LEAK OR SPILL, ESPECIALLY IF THE VIAL IS INVERTED. IF THE VIAL HAS BEEN INOCULATED, TREAT THE LEAK OR SPILL WITH CAUTION, AS PATHOGENIC ORGANISMS/AGENTS MAY BE PRESENT. BEFORE DISCARDING, STERILIZE ALL INOCULATED VIALS BY AUTOCLAVING. NO CORRECTIVE ACTIONS WERE REQUIRED. A CROSS FUNCTIONAL TEAM CONTINUALLY MONITORS ALL PRODUCT COMPLAINTS FOR TRENDS AND DETERMINES IF ANY ADDITIONAL ACTIONS ARE NECESSARY BEYOND THE CURRENT INVESTIGATIONAL PROCESS.

Additional Manufacturer Narrative · 0

E.1. INITIAL REPORTER PHONE #: (B)(6). A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BACTEC PLASTIC MYCOSIS IC/F MEDIUM PATIENT BLOOD INITIALLY FLOWED INTO THE BOTTLE. HOWEVER, THERE WAS THEN A BACKFLOW OF APPROXIMATELY 1 ML OF THE MEDIUM INTO THE PATIENT'S VEIN. THE SAMPLE WAS TAKEN FROM A PERIPHERAL VENOUS CATHETER WHILE USING A BLOOD CULTURE ADAPTER FROM SARSTEDT. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BACTEC PLASTIC MYCOSIS IC/F MEDIUM PATIENT BLOOD INITIALLY FLOWED INTO THE BOTTLE. HOWEVER, THERE WAS THEN A BACKFLOW OF APPROXIMATELY 1 ML OF THE MEDIUM INTO THE PATIENT'S VEIN. THE SAMPLE WAS TAKEN FROM A PERIPHERAL VENOUS CATHETER WHILE USING A BLOOD CULTURE ADAPTER FROM SARSTEDT. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1480968 BACTEC PLASTIC MYCOSIS IC/F MEDIUM SYSTEM, BLOOD CULTURING MDB BECTON DICKINSON CARIBE LTD. 5073093 00382904420178

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown